Overview
In this presentation, CPC’s Maria Bollensen reviews the benefits of modular systems used in manufacturing biologics and how to ensure that your process remains closed. Both modular and single-use systems present the means to reduce costs, increase productivity, improve quality, reduce risk, and increase flexibility in biopharmaceutical applications.
Attendees will also gain insight into:
- Closed-system processing and benefits of a modular system design
- Testing for process manufacturing to ensure the best outcomes
- New standardization coming with United States Pharmacopeia (USP) <665> and USP <383>
- Managing Risk + Process Efficiency: The process defines the product
- Bioprocessing solutions + Innovation Review: Addressing the bioprocessing goals
Originally presented at BioProcess International Spring Digital Week 2025